| Literature DB >> 32772505 |
Lorena Dos Santos Castro1, Lívia Bracht1, Rosane Marina Peralta1, Heloisa Vialle Pereira Maróstica1, Jurandir Fernando Comar1, Anacharis Babeto de Sá-Nakanishi1, Adelar Bracht1.
Abstract
The actions of resveratrol in brain and plasma of rats with adjuvant-induced arthritis were investigated. Resveratrol was administered orally during a period of 23 days. A major concern of the present work was to explore an ample range of daily doses (10-200 mg/kg). Several oxidative and inflammatory markers were measured. Important effects of resveratrol treatment were the normalization of the plasma myeloperoxidase activity (inflammatory marker), the normalization of the brain xanthine oxidase activity (reactive oxygen species source) and the near-normalization of the catalase activity in the brain (antioxidant defence). These effects presented obvious dose dependencies in the range up to 200 mg/kg. Resveratrol also reduced protein and lipid damage within the lowest dose ranges investigated, and its action as a free radical scavenger activity was enhanced in brain mitochondria of arthritic rats. Resveratrol failed in restoring the diminished albumin levels and plasma protein thiols in arthritic rats. The latter, however, were substantially increased in healthy rats at low doses (up to 50 mg/kg), a sign of antioxidant action. This increase was reversed at higher doses, a sign of pro-oxidant action. The observations agree with the notion that low doses of resveratrol might be useful as an adjuvant to the conventional antirheumatic drugs.Entities:
Keywords: catalase; lipid damage; myeloperoxidase; protein damage; thiol levels; xanthine oxidase
Mesh:
Substances:
Year: 2020 PMID: 32772505 DOI: 10.1111/bcpt.13475
Source DB: PubMed Journal: Basic Clin Pharmacol Toxicol ISSN: 1742-7835 Impact factor: 4.080